Glenmark Pharmaceuticals informs about press release

29 Apr 2020 Evaluate

Glenmark Pharmaceuticals has informed that it has enclosed press release on 29th April 2020 titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin and Saxagliptin Tablets, 10 mg/5 mg’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1954.80 0.00 (0.00%)
19-Dec-2025 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1746.05
Dr. Reddys Lab 1273.70
Cipla 1505.60
Zydus Lifesciences 913.05
Lupin 2117.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×